Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q4 FY26
Investor Presentation
Q4 FY25
Bearish
5
Neutral
6
Bullish
3
Bearish
35
Neutral
7
Bullish
4
Bearish
30
Neutral
1
Bullish
1
Bearish
30
Neutral
1
Bullish
1
Bearish
30
Neutral
1
Bullish
1
Bearish
30
Neutral
1
Bullish
1
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
22.25 | 32 Cr | 9.44 | 0.32 | 0.00 | 3.11 | 6.17 | 2.03 | ||
19.26 | 31 Cr | 385.20 | 1.84 | 0.00 | 0.45 | 5.14 | 0.00 | ||
97.65 | 31 Cr | 15.08 | 1.46 | 0.00 | -1.83 | -0.78 | 1.56 | ||
11.17 | 30 Cr | -9.96 | 0.04 | 0.00 | -0.35 | -0.32 | -0.19 | ||
370.50 | 27 Cr | 33.07 | 2.88 | 0.00 | 8.70 | 13.79 | 6.78 | ||
41.99 | 25 Cr | -22.87 | 3.72 | 0.00 | -32.67 | -33.18 | -11.68 | ||
22.50 | 22 Cr | -8.10 | 0.00 | 0.00 | -14355.95 | -23.05 | -11.41 | ||
| Median: 7 Co. | — | 22.50 | 30 Cr | 9.44 | 1.46 | 0.00 | -0.35 | -0.32 | 0.00 |
Upcoming Result Date: Nov 06, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Daikaffil Chemicals India Ltd (DAIKAFFI) is currently trading at 40.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Daikaffil Chemicals India Limited manufactures optical brightening agents (OBAs), stilbene derivatives and pigment intermediates from its Tarapur facility, serving textile, paper and detergent industries with an installed OBA capacity around 2,000 metric tonnes per annum and forward-integrated production from key intermediates to finished OBAs. The company’s most recent quarter (ended June 30, 2026) reported standalone revenue of Rs. 102.98 lakhs and a standalone loss after tax of Rs. 62.73 lakhs, reflecting a sharp revenue contraction from the comparable quarter prior year and continued negative profitability for the year ended March 31, 2026. Daikaffil historically adopted Japanese manufacturing technology and forward integration across intermediates and finished OBAs, positioning the company as a significant domestic OBA manufacturer with export-oriented pigment intermediates; the company also prepared consolidated results for the first time after the 2023–24 acquisition by Mikusu India and Heranba. Financials show large inventory swings and cost volatility: cost of materials and inventory movements materially impacted gross margins and led to negative operating results in both standalone and consolidated reporting, indicating working capital and product mix pressures that management must address. The acquisition by Mikusu India with Heranba is positioned as strategic, creating potential for operational synergies, expanded product portfolio and stronger market access, though the investor presentation discloses limited detail on integration plans, capex or explicit revenue targets under new ownership.
Over the past 52 weeks, Daikaffil Chemicals India Ltd has traded between a low of ₹28.48 and a high of ₹121.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Daikaffil Chemicals India Ltd has a market capitalization of approximately 25.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Daikaffil Chemicals India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 25.19 Cr, Daikaffil Chemicals India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Daikaffil Chemicals India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Daikaffil Chemicals India Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Daikaffil Chemicals India Limited manufactures optical brightening agents (OBAs), stilbene derivatives and pigment intermediates from its Tarapur facility, serving textile, paper and detergent industries with an installed OBA capacity around 2,000 metric tonnes per annum and forward-integrated production from key intermediates to finished OBAs.
The company’s most recent quarter (ended June 30, 2026) reported standalone revenue of Rs. 102.98 lakhs and a standalone loss after tax of Rs. 62.73 lakhs, reflecting a sharp revenue contraction from the comparable quarter prior year and continued negative profitability for the year ended March 31, 2026.
Daikaffil historically adopted Japanese manufacturing technology and forward integration across intermediates and finished OBAs, positioning the company as a significant domestic OBA manufacturer with export-oriented pigment intermediates; the company also prepared consolidated results for the first time after the 2023–24 acquisition by Mikusu India and Heranba.
Financials show large inventory swings and cost volatility: cost of materials and inventory movements materially impacted gross margins and led to negative operating results in both standalone and consolidated reporting, indicating working capital and product mix pressures that management must address.
The acquisition by Mikusu India with Heranba is positioned as strategic, creating potential for operational synergies, expanded product portfolio and stronger market access, though the investor presentation discloses limited detail on integration plans, capex or explicit revenue targets under new ownership.
Chemicals & Petrochemicals
Specialty Chemicals
25 Cr
Low Risk
0.0
34.8
—
3.7
121.95
28.48
Sales CAGR
Profit CAGR
ROE
ROCE
